Rising Usage of Rapid Diagnostic Tests that Use Antithrombin Fuel Demand in Antithrombin Market
The rising incidence of various health conditions such as sepsis, disseminated intravascular coagulation or DIC, congenital antithrombin deficiency, and extracorporeal membrane oxygenation or ECMO is anticipated to boost the demand in the global antithrombin market in coming years. Another major driver for the global antithrombin market is the increasing demand and instances of elevated open heart surgeries. Products in the global antithrombin market are absolutely essential for the long term treatment of thrombotic diseases. This is positively influencing the sales as well as production of the antithrombin drugs in the global antithrombin market. Furthermore, rising usage of rapid diagnostic tests that use antithrombin are also triggering an increased need for solutions and protein molecules in the global antithrombin market.
However, rising utilization of biologics as well as high cost associated with antithrombin are two of the key challenges for the growth of the global antithrombin market in coming years. Solutions in the global antithrombin market replicate the antithrombin protein created by the liver in human body. This protein aids in reducing the clotting of the blood by inactivating the thrombin compounds. Products in the global antithrombin market are used in various healthcare scenarios such as cardiac surgeries as well as in antithrombin deficiency disorders. Rising disposable incomes in emerging economies and adoption of new treatment procedures are also some of the major drivers for the global antithrombin market.
Furthermore, increase in the occurrence of venous thromboembolism or VTE is various western economies is fueling the demand in the global antithrombin market. Moreover, rising awareness pertaining to thrombotic diseases and its ill effects on human body such as liver failure, severe burns, and nephrotic syndrome, is also favoring the adoption of the remedies and solutions offered by the players and manufacturers in the global antithrombin market. Furthermore, increase in the usage of solutions in the global antithrombin market for various therapeutic process in the healthcare sector is also anticipated to positively impact the demand dynamics of the global antithrombin market in the next few years.
Request a sample to get extensive insights into the Antithrombin Market
To understand how our report can bring difference to your business strategy, Ask for a brochure
Stuck in a neck-to-neck competition with other brands? Request a custom report on Antithrombin Market
Key players in the global antithrombin treatment market are engaged in regulatory approvals, technologically advanced products, launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global antithrombin treatment market. A few expansion strategies adopted by players operating in the global antithrombin treatment market are:
The report on the global antithrombin treatment market discussed individual strategies, followed by company profiles of manufacturers of antithrombin products. The competitive landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global antithrombin treatment market.
Global Antithrombin Treatment Market – Segmentation
|
Application |
|
|
Source |
|
|
Dosage Form |
|
|
Region |
|
The global antithrombin market was worth US$ 0.50 Bn and is projected to reach a value of US$ 0.79 Bn by the end of 2027
Antithrombin market is anticipated to grow at a CAGR of 5.3% during the forecast period
North America accounted for a major share of the global antithrombin market
Antithrombin market is driven by rising incidence of various health conditions such as sepsis, disseminated intravascular coagulation or DIC, congenital antithrombin deficiency, and extracorporeal membrane oxygenation or ECMO is anticipated to boost the demand in the global market
Key players in the global antithrombin market include rEVO Biologics, Inc., Grifols, Shire plc., CSL Limited, Kedrion S.p.A, Octapharma AG, Dem ilac Inc., Lee Bisolutions, Diapharma and Scripps Laboratories, Inc
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Antithrombin Treatment Market
4. Market Overview
4.1. Introduction
4.1.1. Application Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Antithrombin Treatment Market Analysis and Forecasts, 2017–2027
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis Globally: Snapshot
5.3. Healthcare Industry Overview
6. Global Antithrombin Treatment Market Analysis and Forecasts, By Application
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Global Antithrombin Treatment Market Value Forecast By Application, 2017–2027
6.3.1. Therapeutic
6.3.2. Research
6.3.3. Diagnostics
6.4. Global Antithrombin Treatment Market Attractiveness By Application
7. Global Antithrombin Treatment Market Analysis and Forecasts, By Source
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global Antithrombin Treatment Market Value Forecast By Source, 2017–2027
7.3.1. Human
7.3.2. Goat Milk
7.3.3. Others (Bovine, etc.)
7.4. Global Antithrombin Treatment Market Attractiveness By Source
8. Global Antithrombin Treatment Analysis and Forecasts, By Dosage Form
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Global Antithrombin Treatment Market Value Forecast By Dosage Form, 2017–2027
8.3.1. Lyophilized
8.3.2. Liquid
8.4. Global Antithrombin Treatment Market Attractiveness By Dosage Form
9. Global Antithrombin Treatment Market Analysis and Forecasts, By Region
9.1. Key Findings
9.2. Global Antithrombin Treatment Market Value Forecast By Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Global Antithrombin Treatment Market Attractiveness By Country/Region
10. North America Antithrombin Treatment Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. North America Antithrombin Treatment Market Value Forecast By Application, 2017–2027
10.2.1. Therapeutic
10.2.2. Research
10.2.3. Diagnostics
10.3. North America Antithrombin Treatment Market Value Forecast By Source, 2017–2027
10.3.1. Human
10.3.2. Goat Milk
10.3.3. Others (Bovine, etc.)
10.4. North America Antithrombin Treatment Market Value Forecast By Dosage Form, 2017–2027
10.4.1. Lyophilized
10.4.2. Liquid
10.5. North America Antithrombin Treatment Market Value Forecast By Country, 2017–2027
10.5.1. U.S.
10.5.2. Canada
10.6. North America Antithrombin Treatment Market Attractiveness Analysis
10.6.1. By Application
10.6.2. By Source
10.6.3. By Dosage Form
10.6.4. By Country
11. Europe Antithrombin Treatment Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Europe Antithrombin Treatment Market Value Forecast By Application, 2017–2027
11.2.1. Therapeutic
11.2.2. Research
11.2.3. Diagnostics
11.3. Europe Antithrombin Treatment Market Value Forecast By Source, 2017–2027
11.3.1. Human
11.3.2. Goat Milk
11.3.3. Others (Bovine, etc.)
11.4. Europe Antithrombin Treatment Market Value Forecast By Dosage Form, 2017–2027
11.4.1. Lyophilized
11.4.2. Liquid
11.5. Europe Antithrombin Treatment Market Value Forecast By Country/Sub-region, 2017–2027
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Europe Antithrombin Treatment Market Attractiveness Analysis
11.6.1. By Application
11.6.2. By Source
11.6.3. By Dosage Form
11.6.4. By Country/Sub-region
12. Asia Pacific Antithrombin Treatment Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Asia Pacific Antithrombin Treatment Market Value Forecast By Application, 2017–2027
12.2.1. Therapeutic
12.2.2. Research
12.2.3. Diagnostics
12.3. Asia Pacific Antithrombin Treatment Market Value Forecast By Source, 2017–2027
12.3.1. Human
12.3.2. Goat Milk
12.3.3. Others (Bovine, etc.)
12.4. Asia Pacific Antithrombin Treatment Market Value Forecast By Dosage Form, 2017–2027
12.4.1. Lyophilized
12.4.2. Liquid
12.5. Asia Pacific Antithrombin Treatment Market Value Forecast By Country/Sub-region, 2017–2027
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Asia Pacific Antithrombin Treatment Market Attractiveness Analysis
12.6.1. By Application
12.6.2. By Source
12.6.3. By Dosage Form
12.6.4. By Country/Sub-region
13. Latin America Antithrombin Treatment Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Latin America Antithrombin Treatment Market Value Forecast By Application, 2017–2027
13.2.1. Therapeutic
13.2.2. Research
13.2.3. Diagnostics
13.3. Latin America Antithrombin Treatment Market Value Forecast By Source, 2017–2027
13.3.1. Human
13.3.2. Goat Milk
13.3.3. Others (Bovine, etc.)
13.4. Latin America Antithrombin Treatment Market Value Forecast By Dosage Form, 2017–2027
13.4.1. Lyophilized
13.4.2. Liquid
13.5. Latin America Antithrombin Treatment Market Value Forecast By Country/Sub-region, 2017–2027
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America Antithrombin Treatment Market Attractiveness Analysis
13.6.1. By Application
13.6.2. By Source
13.6.3. By Dosage Form
13.6.4. By Country/Sub-region
14. Middle East & Africa Antithrombin Treatment Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Middle East & Africa Antithrombin Treatment Market Value Forecast By Application, 2017–2027
14.2.1. Therapeutic
14.2.2. Research
14.2.3. Diagnostics
14.3. Middle East & Africa Antithrombin Treatment Market Value Forecast By Source, 2017–2027
14.3.1. Human
14.3.2. Goat Milk
14.3.3. Others (Bovine, etc.)
14.4. Middle East & Africa Antithrombin Treatment Market Value Forecast By Dosage Form, 2017–2027
14.4.1. Lyophilized
14.4.2. Liquid
14.5. Middle East & Africa Antithrombin Treatment Market Value Forecast By Country/Sub-region, 2017–2027
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Middle East & Africa Antithrombin Treatment Market Attractiveness Analysis
14.6.1. By Application
14.6.2. By Source
14.6.3. By Dosage Form
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competition Matrix (By Tier and Size of companies)
15.2. Market Share Analysis/Ranking By Company (2018)
15.3. Company Profiles
15.3.1. rEVO Biologics, Inc.
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Growth Strategies
15.3.1.3. SWOT Analysis.
15.3.2. Grifols
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Growth Strategies
15.3.2.3. SWOT Analysis.
15.3.3. Shire plc.
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Growth Strategies
15.3.3.3. SWOT Analysis.
15.3.4. CSL Limited
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Growth Strategies
15.3.4.3. SWOT Analysis.
15.3.5. Kedrion S.p.A
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Growth Strategies
15.3.5.3. SWOT Analysis.
15.3.6. Octapharma AG
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Growth Strategies
15.3.6.3. SWOT Analysis.
15.3.7. Dem ilac Inc.
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Growth Strategies
15.3.7.3. SWOT Analysis.
15.3.8. Lee Bisolutions
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Growth Strategies
15.3.8.3. SWOT Analysis.
15.3.9. Diapharma
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Growth Strategies
15.3.9.3. SWOT Analysis.
15.3.10. Scripps Laboratories, Inc.
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2. Growth Strategies
15.3.10.3. SWOT Analysis.
List of Table
Table 01: Global Antithrombin Market Size (US$ Mn) Forecast, by Application, 2017–2027
Table 02: Global Antithrombin Market Size (US$ Mn) Forecast, by Source, 2017–2027
Table 03: Global Antithrombin Market Size (US$ Mn) Forecast, by Dosage Form, 2017–2027
Table 04: Global Antithrombin Market Size (US$ Mn) Forecast, by Region, 2017–2027
Table 05: North America Antithrombin Market Size (US$ Mn) Forecast, by Country, 2017–2027
Table 06: North America Antithrombin Market Size (US$ Mn) Forecast, by Application, 2017–2027
Table 07: North America Antithrombin Market Size (US$ Mn) Forecast, by Source, 2017–2027
Table 08: North America Antithrombin Market Size (US$ Mn) Forecast, by Dosage Form, 2017–2027
Table 09: Europe Antithrombin Market Size (US$ Mn) Forecast, by Country, 2017–2027
Table 10: Europe Antithrombin Market Size (US$ Mn) Forecast, by Application, 2017–2027
Table 11: Europe Antithrombin Market Size (US$ Mn) Forecast, by Source, 2017–2027
Table 12: Europe Antithrombin Market Size (US$ Mn) Forecast, by Dosage Form, 2017–2027
Table 13: Asia Pacific Antithrombin Market Size (US$ Mn) Forecast, by Country, 2017–2027
Table 14: Asia Pacific Antithrombin Market Size (US$ Mn) Forecast, by Application, 2017–2027
Table 15: Asia Pacific Antithrombin Market Size (US$ Mn) Forecast, by Source, 2017–2027
Table 16: Asia Pacific Antithrombin Market Size (US$ Mn) Forecast, by Dosage Form, 2017–2027
Table 17: Latin America Antithrombin Market Size (US$ Mn) Forecast, by Country, 2017–2027
Table 18: Latin America Antithrombin Market Size (US$ Mn) Forecast, by Application, 2017–2027
Table 19: Latin America Antithrombin Market Size (US$ Mn) Forecast, by Source, 2017–2027
Table 20: Latin America Antithrombin Market Size (US$ Mn) Forecast, by Dosage Form, 2017–2027
Table 21: Middle East & Africa Antithrombin Market Size (US$ Mn) Forecast, by Application, 2017–2027
Table 22: Middle East & Africa Size (US$ Mn) Forecast, by Source, 2017–2027
Table 23: Middle East & Africa Antithrombin Market Size (US$ Mn) Forecast, by Dosage Form, 2017–2027
List of Figure
Figure 01: Global Antithrombin Market Size (US$ Mn) Forecast, 2017–2027
Figure 02: Market Value Share, by Region 2018
Figure 03: Market Value Share, by Application 2018
Figure 04: Market Value Share, by Source 2018
Figure 05: Market Value Share, by Dosage Form 2018
Figure 06: Global Antithrombin Market Value Share Analysis, by Application, 2018 and 2027
Figure 07: Global Antithrombin Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Therapeutic, 2017–2027
Figure 08: Global Antithrombin Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Research, 2017–2027
Figure 09: Global Antithrombin Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Therapeutic, 2017–2027
Figure 10: Global Antithrombin Market Attractiveness Analysis, by Application, 2019–2027
Figure 11: Global Antithrombin Market Value Share Analysis, by Source, 2018 and 2027
Figure 12: Global Antithrombin Market Revenue (US$ Mn), by Human Source, 2017–2027
Figure 13: Global Antithrombin Market Revenue (US$ Mn), by Goat Milk Source, 2017–2027
Figure 14: Global Antithrombin Market Revenue (US$ Mn), by Others, 2017–2027
Figure 15: Global Antithrombin Market Attractiveness Analysis, by Source, 2019–2027
Figure 16: Global Antithrombin Market Value Share Analysis, by Dosage Form, 2018 and 2027
Figure 17: Global Antithrombin Market Revenue (US$ Mn), by Lyophilized Dosage Form, 2017–2027
Figure 18: Global Antithrombin Market Revenue (US$ Mn), by Liquid Dosage Form, 2017–2027
Figure 19: Global Antithrombin Market Attractiveness Analysis, by Dosage Form, 2019–2027
Figure 20: Global Antithrombin Market Value Share Analysis, by Region, 2018 and 2027
Figure 21: Global Antithrombin Market Attractiveness Analysis, by Region, 2017–2027
Figure 22: North America Antithrombin Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027
Figure 23: North America Antithrombin Market Attractiveness Analysis, by Country, 2019–2027
Figure 24: North America Antithrombin Market Value Share Analysis, by Country, 2018 and 2027
Figure 25: North America Antithrombin Market Value Share Analysis, by Application, 2018 and 2027
Figure 26: North America Antithrombin Market Value Share Analysis, by Source, 2018 and 2027
Figure 27: North America Antithrombin Market Value Share Analysis, by Dosage Form, 2018 and 2027
Figure 28: North America Antithrombin Market Attractiveness Analysis, by Application, 2019–2027
Figure 29: North America Antithrombin Market Attractiveness Analysis, by Source, 2019–2027
Figure 30:North America Antithrombin Market Attractiveness Analysis, by Dosage Form, 2019–2027
Figure 31: Europe Antithrombin Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027
Figure 32: Europe Antithrombin Market Attractiveness Analysis, by Country, 2019–2027
Figure 33: Europe Antithrombin Market Value Share Analysis, by Country, 2018 and 2027
Figure 34: Europe Antithrombin Market Value Share Analysis, by Application, 2018 and 2027
Figure 35: Europe Antithrombin Market Value Share Analysis, by Source, 2018 and 2027
Figure 36: Europe Antithrombin Market Value Share Analysis, by Dosage Form, 2018 and 2027
Figure 37: Europe Antithrombin Market Attractiveness Analysis, by Application, 2019–2027
Figure 38: Europe Antithrombin Market Attractiveness Analysis, by Source, 2019–2027
Figure 39: Europe Antithrombin Market Attractiveness Analysis, by Dosage Form, 2019–2027
Figure 40: Asia Pacific Antithrombin Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2027
Figure 41: Asia Pacific Antithrombin Market Attractiveness Analysis, by Country, 2019–2027
Figure 42: Asia Pacific Antithrombin Market Value Share Analysis, by Country, 2018 and 2027
Figure 43: Asia Pacific Antithrombin Market Value Share Analysis, by Application, 2018 and 2027
Figure 44: Asia Pacific Antithrombin Market Value Share Analysis, by Source, 2018 and 2027
Figure 45: Asia Pacific Antithrombin Market Value Share Analysis, by Dosage Form, 2018 and 2027
Figure 46: Asia Pacific Antithrombin Market Attractiveness Analysis, by Application, 2019–2027
Figure 47: Asia Pacific Antithrombin Market Attractiveness Analysis, by Source, 2019–2027
Figure 48:Asia Pacific Antithrombin Market Attractiveness Analysis, by Dosage Form, 2019–2027
Figure 49: Latin America Antithrombin Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027
Figure 50: Latin America Antithrombin Market Attractiveness Analysis, by Country, 2019–2027
Figure 51: Latin America Antithrombin Market Value Share Analysis, by Country, 2018 and 2027
Figure 52: Latin America Antithrombin Market Value Share Analysis, by Application, 2018 and 2027
Figure 53: Latin America Antithrombin Market Value Share Analysis, by Source, 2018 and 2027
Figure 54: Latin America Antithrombin Market Value Share Analysis, by Dosage Form, 2018 and 2027
Figure 55: Latin America Antithrombin Market Attractiveness Analysis, by Application, 2019–2027
Figure 56: Latin America Antithrombin Market Attractiveness Analysis, by Source, 2019–2027
Figure 57: Latin America Antithrombin Market Attractiveness Analysis, by Dosage Form, 2019–2027
Figure 58: Middle East & Africa Antithrombin Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027
Figure 59: Middle East & Africa Antithrombin Market Value Share Analysis, by Application, 2018 and 2027
Figure 60: Middle East & Africa Antithrombin Market Value Share Analysis, by Source, 2018 and 2027
Figure 61: Rest of the World Antithrombin Market Value Share Analysis, by Dosage Form, 2018 and 2027
Figure 62: Middle East & Africa Antithrombin Market Attractiveness Analysis, by Application, 2019–2027
Figure 63: Middle East & Africa Antithrombin Market Attractiveness Analysis, by Source, 2019–2027
Figure 64: Middle East & Africa Antithrombin Market Attractiveness Analysis, by Dosage Form, 2019–2027
Figure 65: Heat Map Analysis By Company 2018
Figure 66: Revenue for the LFB Group (US$ Mn) and Y-o-Y Growth (%), 2014–2018
Figure 67: Breakdown of Net Sales, by Business Segment, 2018
Figure 68: Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2018
Figure 69: Breakdown of Net Sales, by Business Segment, 2018
Figure 70: Revenue (US$ Bn) and Y-o-Y Growth (%), 2014–2018
Figure 71: Breakdown of Net Sales, by Region, 2018
Figure 72: CSL Limited Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2018
Figure 73: Breakdown of Net Sales by Business segments, 2018
Figure 74: Company Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2018
Figure 75: Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2018
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Antithrombin Market Forecast, 2019-2027
*86 figures and 60 tables includes